Examkin

Question

Difficulty: MediumImmunologic and Inflammatory Processes

A 38-year-old man comes to the transplant clinic for urgent evaluation due to a 2-day history of decreased urine output, fatigue, and low-grade fever. He underwent a deceased-donor renal transplantation 6 weeks ago for end-stage renal disease secondary to IgA nephropathy. His current medications include tacrolimus, mycophenolate mofetil, and prednisone. Temperature is 37.8°C (100.0°F), blood pressure is 155/95 mmHg, and pulse is 92/min. Physical examination reveals tenderness over the allograft in the right lower quadrant. Laboratory studies show a serum creatinine of 2.9 mg/dL, increased from a baseline of 1.3 mg/dL one week ago. Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for the management of this patient's suspected acute rejection.

  1. 1Obtain a renal allograft ultrasound with Doppler
  2. 2Perform a percutaneous renal allograft biopsy
  3. 3Administer high-dose intravenous methylprednisolone
  4. 4Monitor graft function for steroid-refractory rejection
  5. 5Administer anti-thymocyte globulin (ATG)

Answer

The correct sequence for managing suspected acute transplant rejection is to first rule out structural causes with a renal ultrasound, followed by a renal biopsy for definitive tissue diagnosis. Once acute cellular rejection is confirmed, first-line therapy with high-dose intravenous methylprednisolone is administered. The patient is then monitored for clinical response; if the rejection proves to be steroid-refractory, second-line therapy with a lymphocyte-depleting agent like anti-thymocyte globulin is initiated.
The optimal management of acute renal allograft dysfunction follows a logical progression from non-invasive triage to definitive diagnosis and stepwise treatment. An ultrasound with Doppler is always the first step to quickly exclude reversible surgical or vascular complications. A biopsy is then necessary to determine the exact immunopathologic mechanism. Once acute cellular rejection is diagnosed, high-dose corticosteroids are the standard first-line therapy. Subsequent monitoring dictates whether escalation to potent lymphocyte-depleting agents like anti-thymocyte globulin is necessary for steroid-refractory disease.

Step-by-Step Solution

1
Exclude structural or vascular causes
Renal allograft ultrasound with Doppler is performed.
Vascular thrombosis, urinary obstruction, or perigraft fluid collections can present identically to rejection and must be ruled out non-invasively first.
2
Obtain definitive histologic diagnosis
Percutaneous renal allograft biopsy is performed.
Tissue diagnosis is required to differentiate acute cellular rejection from antibody-mediated rejection, polyomavirus (BK) nephropathy, and medication toxicity.
3
Initiate first-line immunosuppressive therapy
High-dose intravenous methylprednisolone is administered.
Pulse corticosteroids represent the standard initial treatment for acute cellular rejection.
4
Evaluate response to initial targeted therapy
Graft function is monitored.
A subset of patients will have severe or steroid-resistant rejection, requiring close follow-up of serum creatinine.
5
Escalate therapy for refractory cases
Anti-thymocyte globulin is administered.
Steroid-refractory rejection necessitates potent T-cell depleting agents as salvage therapy.

Key Concept

The standard approach to acute renal transplant dysfunction involves sequential exclusion of post-surgical and vascular complications, definitive tissue diagnosis via biopsy, and stepwise immunomodulatory therapy starting with pulse steroids and escalating to lymphocyte-depleting agents for refractory cases.
Rate this question

Topics

Immunologic and Inflammatory Processes

More questions from this topic